Lauder, Sarah N., Pires, Ana, Somerville, Michelle, Capitani, Lorenzo, Smart, Kathryn, Geary, James, Mills, Emily M., Vanhaesebroeck, Bart, Godkin, Andrew ORCID: https://orcid.org/0000-0002-1910-7567 and Gallimore, Awen ORCID: https://orcid.org/0000-0001-6675-7004
2026.
Optimising anti-PI3Kd and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple negative breast cancer improves outcome by removing treatment-related adverse events.
Journal for ImmunoTherapy of Cancer
Item availability restricted. |
|
|